In vitro activation and enzyme kinetic analysis of recombinant midgut serine proteases from the Dengue vector mosquito Aedes aegypti
© Rascón et al; licensee BioMed Central Ltd. 2011
Received: 21 April 2011
Accepted: 9 August 2011
Published: 9 August 2011
The major Dengue virus vector Aedes aegypti requires nutrients obtained from blood meal proteins to complete the gonotrophic cycle. Although bioinformatic analyses of Ae. aegypti midgut serine proteases have provided evolutionary insights, very little is known about the biochemical activity of these digestive enzymes.
We used peptide specific antibodies to show that midgut serine proteases are expressed as zymogen precursors, which are cleaved to the mature form after blood feeding. Since midgut protein levels are insufficient to purify active proteases directly from blood fed mosquitoes, we engineered recombinant proteins encoding a heterologous enterokinase cleavage site to permit generation of the bona fide mature form of four midgut serine proteases (AaET, AaLT, AaSPVI, AaSPVII) for enzyme kinetic analysis. Cleavage of the chromogenic trypsin substrate BApNA showed that AaET has a catalytic efficiency (kcat/KM) that is ~30 times higher than bovine trypsin, and ~2-3 times higher than AaSPVI and AaSPVII, however, AaLT does not cleave BApNA. To measure the enzyme activities of the mosquito midgut proteases using natural substrates, we developed a quantitative cleavage assay based on cleavage of albumin and hemoglobin proteins. These studies revealed that the recombinant AaLT enzyme was indeed catalytically active, and cleaved albumin and hemoglobin with equivalent efficiency to that of AaET, AaSPVI, and AaSPVII. Structural modeling of the AaLT and AaSPVI mature forms indicated that AaLT is most similar to serine collagenases, whereas AaSPVI appears to be a classic trypsin.
These data show that in vitro activation of recombinant serine proteases containing a heterologous enterokinase cleavage site can be used to investigate enzyme kinetics and substrate cleavage properties of biologically important mosquito proteases.
Keywordstrypsin Aedes aegypti hemoglobin serum albumin zymogen
Female mosquitoes must acquire a blood meal from vertebrate hosts in order to obtain the proper nutrients for completion of the gonotrophic cycle . The site of blood meal digestion and nutrient absorption is localized in the midgut, which is also the entry site for blood-borne human pathogens. The blood feeding behavior of mosquitoes facilitates the transmission of many human pathogens, including Dengue and yellow fever viruses, and malarial parasites . Because of the resurgence in Dengue fever in tropical and subtropical regions of the world [3, 4], and the global persistence of malarial parasite infections , it is critical to understand biochemical processes required for blood meal metabolism as a means to develop effective vector control strategies.
Blood feeding in the Dengue mosquito, Aedes aegypti, induces the release of proteolytic enzymes in the mosquito midgut, which leads to the degradation of blood meal proteins into peptides and amino acids. These blood protein-derived peptides and amino acids are required for the synthesis of lipid and carbohydrate stores, and as a source of energy for egg production. The major classes of digestive enzymes in blood fed female Ae. aegypti mosquitoes are trypsins [6, 7], chymotrypsins [8, 9], aminopeptidases [8, 10], and carboxypeptidases [11, 12]. Based on cleavage of the trypsin substrate analog BApNA (Nα-benzoyl-D, L-arginine p-nitroanilide), we recently showed that trypsin-like activity in midgut extracts of dsRNA-injected blood fed Ae. aegypti mosquitoes was primarily due to two serine proteases . One is the early phase trypsin, AaET, and the other, is a late phase trypsin named AaSPVI, which is a member of the 5G1 superfamily . RNAi based studies using BApNA assays to analyze midgut extracts for trypsin activity from 0-48 hr post blood meal (PBM) showed that AaET is the only trypsin-like protease during the first 1-6 hr PBM, whereas the AaSPVI protease accounts for up to 75% of the BApNA cleaving activity during the late phase of digestion from 12-36 hr PBM . These same experiments also showed that another midgut protease, AaSPVII, contributed significantly to overall fecundity in blood fed mosquitoes. Interestingly, RNAi knock down of AaLT expression, also known as Late Trypsin, had no effect on BApNA activity in midgut extracts, even though it reduced fecundity by ~30% as did the AaSPVI RNAi knock downs . These data suggest that AaSPVI, and not AaLT, is the major late phase midgut trypsin in blood fed Ae. aegypti, and are consistent with bioinformatic analyses of protease encoding genes in the Ae. aegypti genome .
Trypsin belongs to the serine protease family, which includes chymotrypsin, elastase, and serine collagenase . During catalysis, the active site serine becomes deprotonated and functions as a nucleophile attacking the carbonyl of the peptide substrate, leading to the formation of a tetrahedral intermediate . Serine deprotonation by histidine, and stabilization of the newly protonated histidine by a nearby aspartate residue, constitutes a charge relay system consisting of the classic catalytic triad Ser-His-Asp. Structures of a large number of serine proteases have shown that they contain two six-stranded β-barrels and up to six disulfide linkages, which stabilizes the tertiary structure of these often secreted enzymes [18, 19]. The substrate specificity of serine proteases is determined in part by an amino acid residue in the substrate specificity pocket. For example, trypsins contain an aspartate residue at this position and cleave the peptide bond on the carboxyl terminal side of arginine and lysine residues, which form an ionic interaction with the aspartate residue [16, 19]. In contrast, serine collagenases have less well-defined substrate specificity pockets, and hence display a wider range of preferred cleavage sites in protein substrates .
To better understand the biochemical properties of the AaET, AaLT, AaSPVI, and AaSPVII midgut serine proteases, we engineered a heterologous enterokinase cleavage site into the propeptide region of the recombinant proteins and optimized a protein purification protocol using a denaturation/renaturation strategy. We quantitatively measured enzyme activity in the AaET, AaLT, AaSPVI, and AaSPVII proteases using the artificial BApNA substrate, as well as the natural substrates serum albumin and hemoglobin.
Design of enterokinase cleavable forms of four midgut serine proteases
As shown in Figure 1B, we used bioinformatics to predict the most likely propeptide cleavage site in the AaSPVI, AaSPVII, and AaLT proteases based on amino acid sequence alignment, which also included the early phase trypsin, AaET, and bovine trypsinogen. Using the SignalP 3.0 algorithm to detect leader sequences in the full-length proteins , each of the four mosquito serine proteases was predicted to contain a leader sequence targeting the nascent polypeptide to the endoplasmic reticulum. By aligning the amino acid sequences of the four mosquito proteases with that of bovine trypsinogen using ClustalW , it can be seen that the most likely propeptide cleavage site is between the amino acids GR-IV (AaET, AaSPVI) or GR-VV (AaSPVII, AaLT).
We were unable to activate purified zymogen forms of these proteases in vitro, and high level bacterial expression and purification of recombinant mature forms of these four proteases failed to yield sufficient quantities of catalytically active enzymes (data not shown). Therefore, we engineered a heterologous enterokinase cleavage site (DDDDK) into an artificial propeptide region referred to as Mek, which permitted purification of inactive enzyme that could be activated in vitro using commercial preparations of enterokinase [23, 24]. As shown in Figure 1C, the heterologous DDDDK enterokinase cleavage site was linked to the N-terminal sequence MNNNLG derived from pMAL-c4E, which we found to be associated with efficient Mek protein cleavage by enterokinase in an in vitro reaction.
Purification of recombinant mosquito midgut serine proteases in soluble form
Based on other recombinant protease purification protocols that have been described [25–27], we optimized a protein denaturation and refolding strategy to purify soluble Mek forms of the proteases following IPTG induction. We found that the pET29a vector and BL21-DE3 bacterial expression system yielded the highest amounts of AaSPVI-Mek, AaSPVII-Mek, and AaLT-Mek proteins, whereas the AaET-Mek protein was optimally expressed using the pET28a vector. Following denaturation/renaturation, the soluble Mek proteins were cleaved in vitro at 4°C with recombinant enterokinase to remove the propeptide (see Figure 1C), and then further purified using either a benzamidine column for AaSPVI (cleaved AaSPVI-Mek), an ion exchange column for AaSPVII (cleaved AaSPVII-Mek) and AaLT (cleaved AaLT-Mek), or a combination of a Ni2+-chelating column and ion exchange column for AaET (cleaved AaET-Mek).
Enzyme kinetic analysis of mosquito proteases using BApNA as a substrate
Steady-state kinetic parameters of mosquito proteases and bovine trypsin using BApNA as a substrate
K M(BApNA) (μM)
k cat (s -1 )
k cat /K M (mM -1 s -1 )
(μmol min -1 (mg of protein) -1 )
63.0 ± 1.3
11.8 ± 0.3
19.2 ± 1.0
1051 ± 54
Enzyme activity assays based on in vitro cleavage of albumin and hemoglobin
Protease activity analysis using the natural substrates serum albumin and hemoglobin
0.253 ± 0.027
1.66 ± 0.08
0.341 ± 0.008
5.34 ± 0.43
0.247 ± 0.014
1.60 ± 0.08
0.294 ± 0.003
1.61 ± 0.15
0.291 ± 0.016
5.53 ± 0.12
Taken together, these BSA and Hb cleavage assays confirm recent in vivo functional studies using RNAi [13, 29] demonstrating that all four of these major mosquito midgut proteases encode high levels of proteolytic activity against the two most abundant blood meal proteins, despite the fact that AaLT does not cleave BApNA.
Structural homology modeling indicates AaLT is a serine collagenase
Biochemical studies of proteases are challenging for two reasons. First, most proteases are present at low amounts in tissues, and therefore must be isolated as recombinant proteins, usually from bacterial sources. However, since bacterial cells maintain a reducing environment, eukaryotic serine proteases expressed in bacterial cells are often improperly folded and localized to inclusion bodies as insoluble proteins. Second, activated proteases will autodigest if not purified under inhibitory conditions, which for structural studies of serine proteases can be done using covalent modification of the active site serine with diisopropylfluorophosphate. However, to conduct enzyme kinetic analyses, the inhibition must be reversible, or if the inactive zymogen form of the enzyme is purified, it needs to be cleaved in vitro using a readily available activating enzyme. As has been done in several other studies in which recombinant serine proteases were expressed in bacteria [25–27], we solved both the solubility and degradation problems. This was done by using a denaturation/renaturation protocol to refold soluble proteins, and by engineering in a heterologous cleavage site into the propeptide region to control in vitro activation (see Figure 1). This combined experimental approach allowed us to answer three important questions in the field of mosquito biology, 1) which kinetic parameters differentiate the four most abundant midgut serine proteases in blood fed Ae. aegypti mosquitoes?, 2) are the BApNA cleaving activities of these four enzymes similar to the activities determined by an in vitro cleaving assay using natural protein substrates, such as albumin and hemoglobin?, and 3) if the late phase AaLT serine protease is not a trypsin-like enzyme, then what is it?
Using the substrate analog BApNA, we showed that AaET is indeed a trypsin-like enzyme cleaving BApNA more efficiently (in terms of kcat and kcat/KM) than the three other mosquito serine proteases analyzed, including bovine trypsin (Table 1). In addition, we demonstrated that AaSPVII is also a trypsin-like enzyme, cleaving BApNA more efficiently than AaSPVI. This is an important finding because our earlier in vivo functional studies using an RNAi strategy, suggested that AaSPVII contributed very little to the BApNA activity in midgut protein extracts . Surprisingly, AaSPVI, which was shown to be responsible for ~75% of the BApNA cleaving activity in midgut extracts in these same experiments, had the lowest specific activity in our in vitro BApNA assays, owing to a low turnover rate as defined by kcat (Table 1). It had previously been proposed that AaLT might not be a trypsin based on the presence of a serine residue, rather than an aspartate residue, in the specificity pocket [6, 29]. We were able to directly test this prediction using purified active AaLT protein, and found that AaLT was indeed lacking BApNA cleaving activity, despite having similar rates of digestion to that of AaET and AaSPVI using BSA and Hb as substrates (Table 2). This result is consistent with a recent bioinformatic analysis indicating that AaLT is more closely related to serine collagenases than trypsins , since most serine collagenases do not cleave the substrate analog BApNA .
Structural homology modeling of AaLT was done using a 1.8Å serine collagenase structure from heel fly that was 40% identical to AaLT at the amino acid level (Figure 5). It can be seen from this model that a serine residue sits at the bottom of the specificity pockets of AaLT (S203) and the heel fly collagenase (S189), rather than an aspartate residue as in AaSPVI (D215) and all other bona fide trypsins . It is likely that this amino acid difference in the specificity pocket of AaLT is responsible for the lack of BApNA cleaving activity. Moreover, similar to the heel fly collagenase , AaLT might recognize and cleave after Leu residues, rather than Arg residues, given that both enzymes contain serine residues in the specificity pocket. However, further studies are needed to test this prediction.
Why would blood fed mosquitoes secrete a collagenase-like enzyme into the midgut, considering that human blood contains very little, if any, collagen? One explanation might be that serine collagenases have been shown to be somewhat promiscuous with regard to substrate specificity, and therefore could function as garbage disposals in the digestion system, much like proteosomes do in the cytoplasm to degrade cellular proteins. This notion comes from the extensive biochemical analysis of a serine collagenase from the fiddler crab (Uca pugilator), which has a 37% sequence identity to AaLT. These studies showed that the crab enzyme is a true collagenase, however, it was also found to have trypsin-, chymotrypsin-, and elastase-like substrate specificities and cleavage activities owing to a substrate specificity pocket that accommodates different basic, polar, and hydrophobic amino acids [20, 32, 33]. For a mosquito to have such an enzyme would be advantageous, since the mosquito must digest the blood meal fairly quickly in order to obtain the proper nutrients to fuel the gonotrophic cycle.
Serine proteases expressed in the midgut of blood fed Ae. aegypti mosquitoes are required for protein digestion and completion of the gonotrophic cycle, and could potentially be selective inhibitor targets for vector control. In order to quantitate enzyme activities in the four most abundant midgut serine proteases in Ae. aegypti, we engineered a heterologous enterokinase cleavage site into an artificial propeptide region to permit the purification and in vitro activation of recombinant enzymes. We found that three of the four proteases (AaET, AaSPVI, AaSPVII) cleave the trypsin analog BApNA in an in vitro assay, which confirms that they are trypsin-like serine proteases, whereas a fourth enzyme, misnamed late trypsin (AaLT), does not cleave BApNA and is structurally related to serine collagenases.
Chemicals and antibodies
Tris(hydroxymethyl)aminomethane (TRIS), calcium chloride, sodium chloride, guanidium hydrochloride, and DMSO were all purchased from EMD Sciences (Gibbstown, NJ), and are of reagent grade or better. Custom midgut protease polyclonal rabbit antibodies were generated by GenScript (Piscataway, NJ) and have been previously described . Conjugated secondary antibodies used for Western blotting were obtained from Li-Cor (Lincoln, NE).
Construction of bacterial expression plasmids
Primers used for PCR amplification and cloning of recombinant forms of AaET, AaSPVI, AaSPVII, and AaLT, without (Zymogen), or with, an enterokinase cleavage site (Mek)
5'-AAAAACATATG AACAACAACCTCGGCGATGACGATGACAAG ATCGTTGGCGGATTCCAGAT-3'
5'-AAAAACATATG AACAACAACCTCGGCGATGACGATGACAAG ATTGTTGGTGGCTTTGAAGT-3'
5'-AAAAACATATG AACAACAACCTCGGCGATGACGATGACAAG GTCGTCGGCGGTTATGAAGT-3'
5'-AAAAACATATG AACAACAACCTCGGCGATGACGATGACAAG GTAGTAAACGGACAAACGGC-3'
Bacterial expression and protein denaturation/renaturation conditions
The zymogen and Mek plasmid constructs were transformed into the Rosetta2-DE3 and BL21-DE3 bacterial expression systems (Novagen), respectively. A single colony was picked from an overnight plate grown on Luria Broth (LB) agar supplemented with 15 μg/ml kanamycin + 34 μg/ml chloramphenicol (for Rosetta2-DE3 strains) and 34 μg/ml kanamycin (for BL21-DE3 strains), and placed in 0.2 L of LB with the proper antibiotics. The overnight culture was incubated in a 37°C shaker (250 rpm) and grown overnight. From the overnight culture, 6 × 1L LB cultures with the proper antibiotics (in 2.8 L Fernbach flasks) were incubated in a 37°C shaker (200 rpm). At an OD600 ~ 0.7-1.0, the cultures were induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and grown for 4 h. Bacterial cells were harvested by centrifugation at 6,000 rpm for 20 min (4°C). Pellets were then flash frozen in liquid N2 and stored at -80°C until needed.
Both the zymogen and Mek forms of the proteases were insoluble under all growth conditions tested, and therefore proteins were purified from bacterial inclusion bodies and subjected to a protein denaturation/renaturation protocol using guanidine hydrochloride (Gu-HCl). Briefly, 8 g of cell paste was lysed by sonication in buffer containing 20 mM TRIS-HCl + 10 mM CaCl2 + 200 mM NaCl pH 8.0 and 1 mM DTT (lysis buffer). The cells were then centrifuged for 45 min at 16,000 rpm and 4°C. After centrifugation, the inclusion body pellet was washed by sonication (in 15 s bursts, 20% power for a total of 3 min, on ice) using lysis buffer containing 0.5 M Gu-HCl and 2% Triton X-100. The washed cells were then centrifuged at 16,000 rpm (4°C) for 15 min. The wash step was repeated twice and the pellet containing the insoluble and inactive protease was resolubilized using lysis buffer with 6 M Gu-HCl. The protein was then refolded at 4°C using dialysis (4 L 20 mM TRIS-HCl + 10 mM CaCl2 + 200 mM NaCl pH 8.0) with multiple buffer changes to slowly remove the Gu-HCl and DTT. The dialyzed protein was concentrated at 4°C using an N2 gas pressured Amicon concentrator (with a YM-10 membrane, Millipore), aliquoted, flash frozen in liquid N2, and stored at -80°C. The concentrations of all purified and refolded recombinant proteins were determined using the BCA Assay kit (Pierce) with bovine serum albumin (BSA) (Pierce) as a standard.
Activation and purification of the Mek form of recombinant proteases
To remove the artificial leader sequence of the inactive Mek proteins, each refolded protease was treated with recombinant enterokinase (rEK) obtained from New England Biolabs. All purification steps were carried out at 4°C. For AaSPVI-Mek, ~11 mg of protein was treated with ~80 units of rEK and incubated at 4°C for 24 h (reaction set in an Erlenmeyer flask with low agitation using a stir bar and plate). The reaction mixture was then purified using a HiTrap Benzamidine FF 1 ml column (GE Healthcare, Waukesha, WI) that had been equilibrated with 20 mM TRIS-HCl + 10 mM CaCl2 + 200 mM NaCl pH 8.0. The column was then washed with 10 column volumes of equilibration buffer that contained 1 M NaCl and eluted with 15 column volumes of 50 mM Glycine pH 3.0. Addition of 1 M TRIS-HCl pH 8.0 to the elution fractions during purification prevented denaturation of the protein. Fractions were pooled and collected based on SDS-PAGE analysis. The protein buffer was exchanged during concentration to 20 mM TRIS-HCl + 10 mM CaCl2 pH 8.0.
For AaSPVII-Mek and AaLT-Mek, ~35 mg of protein was treated with 60 units of rEK and incubated at 4°C for 48 h as described above. After 48 h, the protein was diluted to obtain a final concentration of NaCl to ~16 mM, and DTT was added to 1 mM to inhibit disulfide bridge formation and minimize autodigestion. The proteins were then loaded and purified using a Q-sepharose HiTrap 5 ml column (GE Healthcare) that had been equilibrated with 20 mM TRIS-HCl + 10 mM CaCl2 + 16 mM NaCl pH 8.0 and 1 mM DTT. The column was washed with 4 column volumes of equilibration buffer and eluted with a linear gradient of increasing NaCl (from 0.016 M to 1 M). Protein fractions were pooled and collected based on SDS-PAGE gel analysis. As a last step in the purification, the proteins were desalted by dialysis at 4°C in 20 mM TRIS-HCl + 10 mM CaCl2 pH 8.0, which helped to remove uncleaved Mek proteins owing to insolubility in low salt.
The activation and purification of AaET-Mek required using the pET28a vector (yielding a His6 tagged protein) in BL21-DE3 cells, as well as a modified purification protocol, owing to low protein expression levels when using the pET29a vector (yielding an untagged native protein). In the first step, ~36 mg of AaET-Mek protein was incubated with 60 units of rEK at 4°C for 24 h, and purified using a Ni2+-charged HiTrap Chelating HP 1 ml column according to the manufacturer's recommendation (GE Healthcare). Protein fractions were pooled and collected based on SDS-PAGE gel analysis, and the protein was buffer-exchanged by dialysis in 20 mM TRIS-HCl + 10 mM CaCl2 pH 8.0 buffer. The protein mixture was diluted to obtain a final concentration of 18 mM NaCl, and 1 mM DTT was added to the mixture and all purification buffers. The protein was then loaded on to a Q-seph column and purified as above. Protein fractions were pooled and collected, and dialyzed in 20 mM TRIS-HCl + 10 M CaCl2 pH 8.0 with 0.5 mM DTT. All active mature protein preps were concentrated using an N2 gas pressured Amicon concentrator (with a YM-10 membrane), aliquoted, flash frozen in liquid N2, and stored at -80°C. The concentrations of all activated and purified recombinant proteins were determined using the BCA Assay kit with bovine serum albumin (BSA) as a standard.
In vitro BApNA Spectrophotometric Assays of Recombinant Proteases
The synthetic chromogenic substrate Nα-benzoyl-D, L-arginine-p-nitroanilide hydrochloride (BApNA) (MP Biomedicals, Solon, OH) was used to test for trypsin-like activity using 20 mM TRIS-HCl, 10 mM CaCl2 pH 8.0, constant enzyme concentration (20 nM (AaET), 50 nM (AaSPVI, AaSPVII, BvT), and 500 nM (AaLT) and varying substrate concentrations (steady-state conditions). Absorbance was measured as a function of time at 405 nm using the CARY WinUV Enzyme Kinetics Application on the CARY 50 UV-visible spectrophotometer (Varian Medical Systems, Palo Alto, CA). All experiments were done in triplicate and presented in Table 1 as mean values ± SEM.
Protease assays using BSA and Hb as substrates
Partial proteolysis of BSA (Sigma Aldrich, St. Louis, MO) was performed by incubating 40 μg of BSA with active mature mosquito proteases (AaET, AaSPVI, and AaLT), or commercial bovine trypsin at a 10:1 mass ratio of BSA to protease, and for AaSPVII, at a mass ratio of 298:1 of BSA to protease. Reactions (0.1 ml) were carried out in 20 mM TRIS-HCl + 10 mM CaCl2 pH 8.0 and 24°C. The 8 μg protein samples (20 μl volume) were withdrawn at 15 and 60 min after the addition of protease, treated with SDS-PAGE sample buffer, and stored at -20°C until all samples collected. Once collected, samples were thawed, incubated at 95°C for 3 min, and analyzed by 12% SDS-PAGE. The SDS-PAGE gel was stained with GelCode Blue Stain Reagent (Thermo Scientific, Fair Lawn, NJ) and destained with high purity water prior to photo documenting.
Activities of the four mosquito proteases and bovine trypsin were determined using BSA and Hb as protein substrates. Reactions were initiated by incubating ~830 ng BSA with ~0.9 ng of protease and incubating ~965 ng Hb with ~4.5 ng protease in 20 mM TRIS-HCl + 10 mM CaCl2 pH 8.0. Reactions (0.15 ml) were carried out at 24°C and samples (15 μl) were withdrawn at t = 0, 1, 2, 3, and 4 h after the addition of protease for all BSA reactions. For AaET, AaSPVII, and AaLT Hb reactions, samples (18 μl) were withdrawn at t = 0, 0.5, 1, 2, 3, and 4 h. For AaSPVI and BT, samples (18 μl) were withdrawn at t = 0, 15, 30, 45, and 60 min. All protein samples were treated with SDS-PAGE sample buffer, which contained a final concentration of 4 mM DTT, and stored at -20°C until all samples collected. Once collected, samples were thawed, set in a 95°C water bath for 3 min, and analyzed by 12% SDS-PAGE (BSA reactions) and 15% SDS-PAGE (Hb reactions). All gels were stained prior to photo documenting using the ProteoSilver Plus Silver Stain kit (Sigma Aldrich) according to the manufacturer's protocol. NIH ImageJ software was used to calculate the pixel density of the protein bands and used to determine the amount of protein substrate (nM), which was then plotted as a function of time (min) to calculate the digestion rate (nM min-1). All experiments were done in triplicate and presented in Table 2 as mean values ± SEM.
Structural homology modeling of AaLT and AaSPVI
The Protein Model Portal (PMP) http://www.proteinmodelportal.org developed by the Swiss Institute of Bioinformatics in Basel was used to identify protein structures that are most similar to the predicted structures of AaLT and AaSPVI as described by Arnold et al. . The best fit for AaLT was a serine collagenase from Hypoderma lineatum (heel fly) that had been solved at 1.8Å resolution (PDB 1hyl), whereas the best fit for AaSPVI was a 1.8Å resolution structure of an anionic Salmon trypsin (PDB 1mbq). A structural alignment of the AaLT and AaSPVI protein models was performed using ICM BrowserPro http://www.molsoft.com software from MolSoft (La Jolla, CA), which is based on the method of Cardozo et al. [34, 35].
Nα-benzoyl-D, L-arginine p-nitroanilide
bovine serum albumin
protein model portal.
We thank Mary Hernandez for rearing mosquitoes, Drs. Chad Park, Nancy Horton, Sue Roberts, and Andrezj Weichsel for expert advice in protein purification and molecular modeling, and Dr. James Hazzard for help in designing and analyzing the enzyme kinetic experiments. This work was supported by the National Institutes of Health grant R01AI031951 to RLM.
- Briegel H: Physiological bases of mosquito ecology. J Vector Ecol. 2003, 28 (1): 1-11.PubMedGoogle Scholar
- Marquardt WC, (ed): Biology of Disease Vectors. 2005, Oxford: Elsevier, 2Google Scholar
- Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E: Dengue: a continuing global threat. Nat Rev Microbiol. 2010, 8 (12 Suppl): S7-S16.PubMedPubMed CentralView ArticleGoogle Scholar
- Kyle JL, Harris E: Global spread and persistence of dengue. Annu Rev Microbiol. 2008, 62: 71-92. 10.1146/annurev.micro.62.081307.163005.PubMedView ArticleGoogle Scholar
- Enayati A, Hemingway J: Malaria management: past, present, and future. Annu Rev Entomol. 2010, 55: 569-591. 10.1146/annurev-ento-112408-085423.PubMedView ArticleGoogle Scholar
- Kalhok SE, Tabak LM, Prosser DE, Brook W, Downe AE, White BN: Isolation, sequencing and characterization of two cDNA clones coding for trypsin-like enzymes from the midgut of Aedes aegypti. Insect Mol Biol. 1993, 2 (2): 71-79. 10.1111/j.1365-2583.1993.tb00127.x.PubMedView ArticleGoogle Scholar
- Barillas-Mury C, Wells MA: Cloning and sequencing of the blood meal-induced late trypsin gene from the mosquito Aedes aegypti and characterization of the upstream regulatory region. Insect Mol Biol. 1993, 2 (1): 7-12. 10.1111/j.1365-2583.1993.tb00119.x.PubMedView ArticleGoogle Scholar
- Bian G, Raikhel AS, Zhu J: Characterization of a juvenile hormone-regulated chymotrypsin-like serine protease gene in Aedes aegypti mosquito. Insect Biochem Mol Biol. 2008, 38 (2): 190-200. 10.1016/j.ibmb.2007.10.008.PubMedPubMed CentralView ArticleGoogle Scholar
- Jiang Q, Hall M, Noriega FG, Wells M: cDNA cloning and pattern of expression of an adult, female-specific chymotrypsin from Aedes aegypti midgut. Insect Biochem Mol Biol. 1997, 27 (4): 283-289. 10.1016/S0965-1748(97)00001-5.PubMedView ArticleGoogle Scholar
- Noriega FG, Edgar KA, Bechet R, Wells MA: Midgut exopeptidase activities in Aedes aegypti are induced by blood feeding. J Insect Physiol. 2002, 48 (2): 205-212. 10.1016/S0022-1910(01)00165-2.PubMedView ArticleGoogle Scholar
- Edwards MJ, Moskalyk LA, Donelly-Doman M, Vlaskova M, Noriega FG, Walker VK, Jacobs-Lorena M: Characterization of a carboxypeptidase A gene from the mosquito, Aedes aegypti. Insect Mol Biol. 2000, 9 (1): 33-38. 10.1046/j.1365-2583.2000.00159.x.PubMedView ArticleGoogle Scholar
- Isoe J, Zamora J, Miesfeld RL: Molecular analysis of the Aedes aegypti carboxypeptidase gene family. Insect Biochem Mol Biol. 2009, 39 (1): 68-73. 10.1016/j.ibmb.2008.09.006.PubMedPubMed CentralView ArticleGoogle Scholar
- Isoe J, Rascon AA, Kunz S, Miesfeld RL: Molecular genetic analysis of midgut serine proteases in Aedes aegypti mosquitoes. Insect Biochem Mol Biol. 2009, 39 (12): 903-912. 10.1016/j.ibmb.2009.10.008.PubMedPubMed CentralView ArticleGoogle Scholar
- Brackney DE, Isoe J, th WCB, Zamora J, Foy BD, Miesfeld RL, Olson KE: Expression profiling and comparative analyses of seven midgut serine proteases from the yellow fever mosquito, Aedes aegypti. J Insect Physiol. 2010, 56 (7): 736-744. 10.1016/j.jinsphys.2010.01.003.PubMedPubMed CentralView ArticleGoogle Scholar
- Venancio TM, Cristofoletti PT, Ferreira C, Verjovski-Almeida S, Terra WR: The Aedes aegypti larval transcriptome: a comparative perspective with emphasis on trypsins and the domain structure of peritrophins. Insect Mol Biol. 2009, 18 (1): 33-44. 10.1111/j.1365-2583.2008.00845.x.PubMedView ArticleGoogle Scholar
- Kraut J: Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem. 1977, 46: 331-358. 10.1146/annurev.bi.46.070177.001555.PubMedView ArticleGoogle Scholar
- Hedstrom L: Serine protease mechanism and specificity. Chem Rev. 2002, 102 (12): 4501-4524. 10.1021/cr000033x.PubMedView ArticleGoogle Scholar
- Stroud RM, Kay LM, Dickerson RE: The structure of bovine trypsin: electron density maps of the inhibited enzyme at 5 Angstrom and at 2-7 Angstron resolution. J Mol Biol. 1974, 83 (2): 185-208. 10.1016/0022-2836(74)90387-8.PubMedView ArticleGoogle Scholar
- Steitz TA, Shulman RG: Crystallographic and NMR studies of the serine proteases. Annu Rev Biophys Bioeng. 1982, 11: 419-444. 10.1146/annurev.bb.11.060182.002223.PubMedView ArticleGoogle Scholar
- Tsu CA, Perona JJ, Fletterick RJ, Craik CS: Structural basis for the broad substrate specificity of fiddler crab collagenolytic serine protease 1. Biochemistry. 1997, 36 (18): 5393-5401. 10.1021/bi961753u.PubMedView ArticleGoogle Scholar
- Erickson BK, Mueller RS, VerBerkmoes NC, Shah M, Singer SW, Thelen MP, Banfield JF, Hettich RL: Computational prediction and experimental validation of signal peptide cleavages in the extracellular proteome of a natural microbial community. J Proteome Res. 2010, 9 (5): 2148-2159. 10.1021/pr900877a.PubMedView ArticleGoogle Scholar
- Aiyar A: The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment. Methods Mol Biol. 2000, 132: 221-241.PubMedGoogle Scholar
- Muhlia-Almazan A, Sanchez-Paz A, Garcia-Carreno FL: Invertebrate trypsins: a review. J Comp Physiol. 2008, 178 (6): 655-672.View ArticleGoogle Scholar
- Whitcomb DC, Lowe ME: Human pancreatic digestive enzymes. Dig Dis Sci. 2007, 52 (1): 1-17. 10.1007/s10620-006-9589-z.PubMedView ArticleGoogle Scholar
- Hohenblum H, Vorauer-Uhl K, Katinger H, Mattanovich D: Bacterial expression and refolding of human trypsinogen. J Bact. 2004, 109 (1-2): 3-11.Google Scholar
- Shan J, Baguinon M, Zheng L, Krishnamoorthi R: Expression, refolding, and activation of the catalytic domain of human blood coagulation factor XII. Protein Expr Purif. 2003, 27 (1): 143-149. 10.1016/S1046-5928(02)00608-3.PubMedView ArticleGoogle Scholar
- Magalhaes CP, Fragoso RR, Souza DS, Barbosa AE, Silva CP, Finardi-Filho F, da Silva MC, Rocha TL, Franco OL, Grossi-de-Sa MF: Molecular and structural characterization of a trypsin highly expressed in larval stage of Zabrotes subfasciatus. Arch Insect Bioc Physiol. 2007, 66 (4): 169-182. 10.1002/arch.20208.View ArticleGoogle Scholar
- Erlanger BF, Kokowsky N, Cohen W: The preparation and properties of two new chromogenic substrates of trypsin. Arch Bioc Biophys. 1961, 95: 271-278. 10.1016/0003-9861(61)90145-X.View ArticleGoogle Scholar
- Brackney DE, Foy BD, Olson KE: The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti. Am J Trop Med Hyg. 2008, 79 (2): 267-274.PubMedPubMed CentralGoogle Scholar
- Arnold K, Kiefer F, Kopp J, Battey JN, Podvinec M, Westbrook JD, Berman HM, Bordoli L, Schwede T: The Protein Model Portal. J Struct Funct Genomics. 2009, 10 (1): 1-8. 10.1007/s10969-008-9048-5.PubMedPubMed CentralView ArticleGoogle Scholar
- Lecroisey A, Keil B: Specificity of the collagenase from the insect Hypoderma lineatum. Euro J Bioc. 1985, 152 (1): 123-130. 10.1111/j.1432-1033.1985.tb09171.x.View ArticleGoogle Scholar
- Tsu CA, Craik CS: Substrate recognition by recombinant serine collagenase 1 from Uca pugilator. J Biol Chem. 1996, 271 (19): 11563-11570. 10.1074/jbc.271.19.11563.PubMedView ArticleGoogle Scholar
- Tsu CA, Perona JJ, Schellenberger V, Turck CW, Craik CS: The substrate specificity of Uca pugilator collagenolytic serine protease 1 correlates with the bovine type I collagen cleavage sites. J Biol Chem. 1994, 269 (30): 19565-19572.PubMedGoogle Scholar
- Cardozo T, Batalov S, Abagyan R: Estimating local backbone structural deviation in homology models. Comput Chem. 2000, 24 (1): 13-31. 10.1016/S0097-8485(99)00044-3.PubMedView ArticleGoogle Scholar
- Cardozo T, Totrov M, Abagyan R: Homology modeling by the ICM method. Proteins. 1995, 23 (3): 403-414. 10.1002/prot.340230314.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.